Micah Anderson
Directeur Général chez LEEF BRANDS INC.
Fortune : 2 M $ au 30/04/2024
Postes actifs de Micah Anderson
Sociétés | Poste | Début | Fin |
---|---|---|---|
LEEF BRANDS INC. | Directeur/Membre du Conseil | 06/09/2022 | - |
Directeur Général | 06/09/2022 | - | |
Leef Holdings, Inc.
Leef Holdings, Inc. Agricultural Commodities/MillingProcess Industries Leef Holdings, Inc. provides investment services. The company was founded in 2019 and is headquartered in La Jolla, CA. | Directeur Général | - | - |
Président | - | - | |
Fondateur | - | - | |
Aya Biosciences, Inc.
Aya Biosciences, Inc. BiotechnologyHealth Technology Aya Biosciences, Inc. is a neuroscience company that is dedicated to improving the mental health and well-being of patients with neuropsychiatric diseases. The company is based in La Jolla, CA. The company is creating a pipeline of novel, orally active serotonin receptor agonists as a new class of therapeutics. The CEO of the company is Micah Anderson. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - |
Historique de carrière de Micah Anderson
Statistiques
Internationale
Etats-Unis | 3 |
Canada | 2 |
Opérationnelle
Chief Executive Officer | 3 |
Director/Board Member | 2 |
Chairman | 1 |
Sectorielle
Process Industries | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
LEEF BRANDS INC. | Process Industries |
Entreprise privées | 2 |
---|---|
Leef Holdings, Inc.
Leef Holdings, Inc. Agricultural Commodities/MillingProcess Industries Leef Holdings, Inc. provides investment services. The company was founded in 2019 and is headquartered in La Jolla, CA. | Process Industries |
Aya Biosciences, Inc.
Aya Biosciences, Inc. BiotechnologyHealth Technology Aya Biosciences, Inc. is a neuroscience company that is dedicated to improving the mental health and well-being of patients with neuropsychiatric diseases. The company is based in La Jolla, CA. The company is creating a pipeline of novel, orally active serotonin receptor agonists as a new class of therapeutics. The CEO of the company is Micah Anderson. | Health Technology |
- Bourse
- Insiders
- Micah Anderson
- Expérience